We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Wants FDA Accusation of “Misuse” Stricken From Public Record
Novartis Wants FDA Accusation of “Misuse” Stricken From Public Record
August 30, 2013
Novartis is asking the FDA to retract from public record accusations it misused the citizen petition process to stall approval of generic versions of Reclast, saying the FDA’s statement is contrary to evidence and “could chill” other drugmakers from submitting concerns in similar circumstances in the future.